Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dizzyness

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Dizzyness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hartman, NG; Lavigne, GJ; Lobbezoo, F; Montplaisir, JY; Soucy, JP1

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dizzyness

ArticleYear
Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials.
    Journal of dental research, 1997, Volume: 76, Issue:9

    Topics: Adult; Benzamides; Bromocriptine; Bruxism; Corpus Striatum; Cross-Over Studies; Dizziness; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Electromyography; Female; Humans; Iodine Radioisotopes; Male; Masseter Muscle; Nausea; Patient Dropouts; Placebos; Polysomnography; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine; Sleep; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

1997
chemdatabank.com